| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $77.0M-33.8% | $116.4M-17.9% | $141.8M+44.1% | $98.4M+63.5% | $60.2M+107.8% | $29.0M |
| General and administrative | $23.9M-8.6% | $26.1M-8.4% | $28.5M-1.9% | $29.0M+24.2% | $23.4M+57.9% | $14.8M |
| Impairment charge | $3.2M | — | — | — | — | — |
| Total operating expenses | $104.0M-27.0% | $142.5M-16.3% | $170.3M+33.6% | $127.4M+52.5% | $83.6M+86.3% | $44.8M |
| Loss from operations | -$104.0M+27.0% | -$142.5M+16.3% | -$170.3M-33.6% | -$127.4M-52.5% | -$83.6M-91.4% | -$43.7M |
| Interest income | $4.0M-57.7% | $9.4M-12.0% | $10.6M+148.9% | $4.3M+4601.1% | $91K-26.6% | $124K |
| Interest expense | -$1.6M+7.3% | -$1.7M-10.5% | -$1.6M-557.6% | -$238K-1730.8% | -$13K | — |
| Other income (expense), net | -$36K-80.0% | -$20K-105.1% | $389K+1868.2% | -$22K-214.3% | -$7K+99.5% | -$1.3M |
| Loss before income taxes | -$101.7M+24.6% | -$134.8M+16.1% | -$160.8M-30.3% | -$123.4M-47.8% | -$83.5M-83.5% | -$45.5M |
| Income tax provision | $0 | $0 | $0 | — | — | -$241K |
| Net loss | -$101.7M+24.6% | -$134.8M+16.1% | -$160.8M-30.2% | -$123.5M-47.9% | -$83.5M-82.5% | -$45.7M |
| Net loss per share, basic | -$1900.00+26.4% | -$2580.00+31.0% | -$3740.00-23.4% | -$3030.00-46.4% | -$2070.00 | — |
| Net loss per share, diluted | -$1900.00+26.4% | -$2580.00+31.0% | -$3740.00-23.4% | -$3030.00-46.4% | -$2070.00 | — |
| Weighted-average shares of common stock used to compute net loss per share, basic | $53658399000.00+2.8% | $52174904000.00+21.4% | $42987767000.00+5.6% | $40699612000.00+1.0% | $40308050000.00+217954.1% | $18485343.00 |
| Weighted-average shares of common stock used to compute net loss per share, diluted | $53658399000.00+2.8% | $52174904000.00+21.4% | $42987767000.00+5.6% | $40699612000.00+1.0% | $40308050000.00+217954.1% | $18485343.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.